Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L SMITH

Showing results (371-380 of 409) with videos related to

Pageof 41
Sort By:
Cancer|February 1, 1990
Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?A U Buzdar, M D McNeese, G N Hortobagyi, et al.
Rhinology|October 2, 2020
The Olfactory Cleft Endoscopy Scale: a multi-institutional validation study in chronic rhinosinusitisR J Schlosser, T L Smith, J C Mace, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemiaF J Giles, J E Cortes, S D Baker, et al.
Blood|July 1, 1994
Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemiaS M Kornblau, H J Xu, W Zhang, et al.
Pathology Oncology Research : POR|November 3, 2001
Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistryF J Esteva, G N Hortobagyi, A A Sahin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemiaH M Kantarjian, M Talpaz, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemiaH M Kantarjian, R S Walters, M J Keating, et al.
Cancer|November 15, 1988
Adjuvant therapy of breast cancer with or without additional treatment with alternate drugsA U Buzdar, G N Hortobagyi, T L Smith, et al.
Blood|December 1, 1985
Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survivalH M Kantarjian, T L Smith, K B McCredie, et al.
Cancer|March 1, 1978
Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancerA U Buzdar, J U Gutterman, G R Blumenschein, et al.
Pageof 41

Showing results (371-380 of 409) with videos related to

Sort By:
Pageof 41
Cancer|February 1, 1990
Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?A U Buzdar, M D McNeese, G N Hortobagyi, et al.
Rhinology|October 2, 2020
The Olfactory Cleft Endoscopy Scale: a multi-institutional validation study in chronic rhinosinusitisR J Schlosser, T L Smith, J C Mace, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemiaF J Giles, J E Cortes, S D Baker, et al.
Blood|July 1, 1994
Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemiaS M Kornblau, H J Xu, W Zhang, et al.
Pathology Oncology Research : POR|November 3, 2001
Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistryF J Esteva, G N Hortobagyi, A A Sahin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemiaH M Kantarjian, M Talpaz, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemiaH M Kantarjian, R S Walters, M J Keating, et al.
Cancer|November 15, 1988
Adjuvant therapy of breast cancer with or without additional treatment with alternate drugsA U Buzdar, G N Hortobagyi, T L Smith, et al.
Blood|December 1, 1985
Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survivalH M Kantarjian, T L Smith, K B McCredie, et al.
Cancer|March 1, 1978
Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancerA U Buzdar, J U Gutterman, G R Blumenschein, et al.
Pageof 41